- Fox News Digital Network
- Fox News
- Fox Business
- uReport
- Fox News Radio
- Fox News Latino
- Fox Nation
- Fox News Insider
Account
Account
U.S. health officials found on Thursday that a class of widely-used blood pressure drugs does not increase the risk of cancer.Last year, a published study reported a small increase in the cancer risk for patients taking medicines called angiotensin receptor blockers (ARBs), and the U.S. Food and Drug Administration launched its own year-long safety review.ARBs are used to treat high blood pressure and other heart-related conditions, and include Novartis's Diovan, Merck's Cozaar, and Avapro from Bristol-Myers Squibb and Sanofi."The FDA has completed its review of controlled trial data on more than 155,000 patients randomized to ARBs or other treatments - the largest evaluation of such data to date - and finds no evidence of an increased risk of cancer in patients who take an ARB," said Mary Ross Southworth, a deputy director for safety in the FDA's Division of Cardiovascular and Renal Drugs.The FDA's conclusion may provide some relief to the big-name makers of ARBs, though they face a l...
A drug commonly used to treat blood pressure, heart failure and diabetes-related kidney damage, was linked to a “modest” increased risk of cancer in a study publishe...
Taking repeated blood pressure readings over a 24-hour period rather than a one-off measurement in the clinic is the most cost-effective way of deciding who should b...
The common blood pressure drug Olmesartan has been found to be linked with symptoms associated with celiac disease – such as nausea, vomiting, diarrhea and electroly...
An experimental drug from Novartis may help up to half of heart failure patients for whom no effective treatment is available, although the evidence so far is indire...
French drug maker Sanofi says its net profit was more than halved in the fourth quarter from a year earlier as mounting restructuring costs and patent losses on key ...
Sanofi saw its earnings slump in the third quarter as generic competitors ate into profits of its Eloxatin cancer treatment.The French drug maker reported Thursday n...
Swiss pharmaceutical giant Novartis AG defended a range of flu drugs that have been banned in Italy, while posting virtually flat third quarter profits as new drugs ...
Swiss drugmaker Novartis said flu vaccines that Italy has banned from sale are safe and it does not expect other countries to take similar action.Italy banned four a...
Swiss pharmaceutical company Novartis AG reported a net profit of $2.73 billion during the second quarter, as new drugs and acquisitions offset patent expirations, l...
Novartis could produce 14 or more new big-selling 'blockbuster' drugs within five years as it bets on cancer, heart and respiratory treatments to fill the gaps left ...
Every day, 10,000 Americans turn 65. More than 80 percent of drivers 65 and older regularly take medication—two-thirds take five or more daily. Yet only half have ta...
Bristol-Myers Squibb Co said it has recalled 64 million tablets of the blood pressure medicine Avalide in the United States and Puerto Rico due to the potential for ...
U.S. health officials are investigating if a class of commonly used blood pressure drugs may increase cancer risk after a recent study raised concern.An analysis of ...
Wholesale prices for the brand-name prescription drugs widely used by older Americans rose at more than twice the rate of inflation during the year that ended March ...
LONDON (AP) — Some of the world's most popular blood pressure pills may slightly increase your risk of getting cancer, but doctors say it's too soon to ditch the dru...
A report in the New England Journal of Medicine highlights one woman's struggle to find a diagnosis after struggling with severe facial swelling.Dr. Didier G. Ebo an...
Women with heart failure, a condition in which the heart fails to pump enough blood to meet the body's demands, may live longer than their male counterparts, a new s...
Some blood pressure medications may reduce the severity of symptoms of post-traumatic stress disorder, a new study suggests.In the study, participants with PTSD who ...
Teva Pharmaceutical Industries has launched U.S. sales of irbesartan and irbesartan-hydrochlorothiazide tablets, generic versions of Sanofi Aventis' high blood press...
This material may not be published, broadcast, rewritten, or redistributed. ©2013 FOX News Network, LLC. All rights reserved. All market data delayed 20 minutes.
